换一批
换一批Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibody.
第一作者：
Xi,Wang
第一单位：
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
作者：
主题词
老年人(Aged);C反应蛋白质(C-Reactive Protein);疾病恶化(Disease Progression);用药计划表(Drug Administration Schedule);食管肿瘤(Esophageal Neoplasms);女(雌)性(Female);人类(Humans);L-乳酸脱氢酶(L-Lactate Dehydrogenase);白细胞计数(Leukocyte Count);男(雄)性(Male);中年人(Middle Aged);预后(Prognosis);回顾性研究(Retrospective Studies);存活率分析(Survival Analysis);治疗结果(Treatment Outcome)
DOI
10.1111/1759-7714.13083
PMID
31017739
发布时间
2020-06-25
- 浏览24
Thoracic cancer
2019年10卷6期
1395-1401页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
